Ernest Vincent Gervino, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chest Pain | 8 | 2019 | 1100 | 1.780 |
Why?
|
| Hypochondriasis | 1 | 2019 | 93 | 0.620 |
Why?
|
| Anxiety | 5 | 2015 | 4671 | 0.620 |
Why?
|
| Attitude to Health | 2 | 2019 | 2020 | 0.600 |
Why?
|
| Models, Psychological | 2 | 2019 | 824 | 0.540 |
Why?
|
| Anxiety Disorders | 2 | 2019 | 2737 | 0.460 |
Why?
|
| Exercise Test | 13 | 2021 | 2180 | 0.410 |
Why?
|
| Internal-External Control | 1 | 2012 | 347 | 0.350 |
Why?
|
| Self-Examination | 1 | 2010 | 72 | 0.330 |
Why?
|
| Coronary Stenosis | 3 | 2021 | 800 | 0.320 |
Why?
|
| Somatoform Disorders | 1 | 2012 | 425 | 0.310 |
Why?
|
| Psychometrics | 2 | 2015 | 3062 | 0.300 |
Why?
|
| Affective Symptoms | 1 | 2011 | 417 | 0.300 |
Why?
|
| Psychophysiologic Disorders | 1 | 2010 | 222 | 0.290 |
Why?
|
| Coronary Disease | 10 | 2013 | 5912 | 0.270 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 6014 | 0.240 |
Why?
|
| Mood Disorders | 1 | 2012 | 1128 | 0.240 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2021 | 669 | 0.230 |
Why?
|
| Electrocardiography | 9 | 2021 | 6404 | 0.230 |
Why?
|
| Coronary Circulation | 5 | 2017 | 1602 | 0.220 |
Why?
|
| Coronary Artery Disease | 10 | 2021 | 6544 | 0.210 |
Why?
|
| Emotions | 1 | 2015 | 2763 | 0.210 |
Why?
|
| Exercise | 7 | 2021 | 5937 | 0.180 |
Why?
|
| Fear | 3 | 2015 | 1499 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2013 | 12240 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2012 | 533 | 0.150 |
Why?
|
| Depression | 2 | 2015 | 8237 | 0.150 |
Why?
|
| Physical Exertion | 4 | 1996 | 665 | 0.150 |
Why?
|
| Diabetic Angiopathies | 2 | 2012 | 805 | 0.140 |
Why?
|
| Thallium Radioisotopes | 2 | 1994 | 135 | 0.130 |
Why?
|
| Exercise Tolerance | 3 | 2019 | 841 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2012 | 4533 | 0.130 |
Why?
|
| Heart | 4 | 2000 | 4414 | 0.120 |
Why?
|
| RNA, Transfer | 1 | 2017 | 283 | 0.120 |
Why?
|
| Middle Aged | 38 | 2021 | 223009 | 0.120 |
Why?
|
| Angina Pectoris | 5 | 2005 | 956 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2013 | 16047 | 0.110 |
Why?
|
| Potassium | 2 | 1996 | 1311 | 0.110 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2013 | 76 | 0.110 |
Why?
|
| Bundle-Branch Block | 1 | 2015 | 280 | 0.110 |
Why?
|
| Male | 46 | 2021 | 363698 | 0.100 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 999 | 0.100 |
Why?
|
| Diabetes Complications | 2 | 2011 | 1316 | 0.100 |
Why?
|
| Female | 43 | 2021 | 396112 | 0.100 |
Why?
|
| Aged | 26 | 2021 | 171117 | 0.100 |
Why?
|
| Myocardial Revascularization | 2 | 2005 | 793 | 0.090 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2005 | 594 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.090 |
Why?
|
| Pyrophosphatases | 1 | 2011 | 141 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2015 | 1237 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2011 | 204 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2010 | 6853 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2016 | 937 | 0.080 |
Why?
|
| Personality Inventory | 1 | 2012 | 1018 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 558 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 707 | 0.070 |
Why?
|
| Albuminuria | 1 | 2012 | 660 | 0.070 |
Why?
|
| Acute Coronary Syndrome | 1 | 2021 | 2184 | 0.070 |
Why?
|
| Sensation | 1 | 2010 | 331 | 0.070 |
Why?
|
| Italy | 4 | 2011 | 854 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2013 | 1180 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2844 | 0.070 |
Why?
|
| Personality | 1 | 2011 | 560 | 0.070 |
Why?
|
| Humans | 51 | 2021 | 765968 | 0.070 |
Why?
|
| Prospective Studies | 7 | 2019 | 54802 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 2817 | 0.070 |
Why?
|
| Radionuclide Imaging | 5 | 2000 | 1978 | 0.070 |
Why?
|
| Adult | 24 | 2019 | 223044 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 11499 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 2128 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2016 | 2692 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2012 | 2352 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 20124 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2780 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 1811 | 0.060 |
Why?
|
| Coronary Angiography | 4 | 2021 | 4493 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2013 | 5370 | 0.060 |
Why?
|
| Arousal | 1 | 2010 | 1171 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 2495 | 0.050 |
Why?
|
| Self Report | 1 | 2015 | 3770 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 2233 | 0.050 |
Why?
|
| Triglycerides | 1 | 2011 | 2441 | 0.050 |
Why?
|
| Case-Control Studies | 7 | 2021 | 22223 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2004 | 393 | 0.050 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2015 | 881 | 0.050 |
Why?
|
| Linkage Disequilibrium | 4 | 2011 | 1997 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2006 | 895 | 0.050 |
Why?
|
| Patient Readmission | 1 | 1996 | 3286 | 0.050 |
Why?
|
| Haplotypes | 2 | 2006 | 2728 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2011 | 6322 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7875 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 2900 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2011 | 3561 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 2660 | 0.040 |
Why?
|
| Hemodynamics | 6 | 1996 | 4184 | 0.040 |
Why?
|
| Inflammation | 2 | 2017 | 10850 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5891 | 0.040 |
Why?
|
| Obesity | 2 | 2011 | 13076 | 0.040 |
Why?
|
| Boston | 4 | 2011 | 9338 | 0.040 |
Why?
|
| Laser Therapy | 1 | 2005 | 1108 | 0.040 |
Why?
|
| Genotype | 5 | 2013 | 13024 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 14751 | 0.040 |
Why?
|
| Purines | 1 | 2021 | 615 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 7123 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 41649 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1999 | 437 | 0.040 |
Why?
|
| Physical Endurance | 3 | 1992 | 368 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2011 | 3985 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2021 | 24282 | 0.030 |
Why?
|
| Kidney | 1 | 2012 | 7066 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 2880 | 0.030 |
Why?
|
| Gene Frequency | 3 | 2011 | 3624 | 0.030 |
Why?
|
| Logistic Models | 3 | 2021 | 13266 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 6493 | 0.030 |
Why?
|
| Bicycling | 1 | 2017 | 176 | 0.030 |
Why?
|
| Hospitalization | 1 | 1996 | 10808 | 0.030 |
Why?
|
| American Heart Association | 1 | 2000 | 1047 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2011 | 18071 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1996 | 242 | 0.030 |
Why?
|
| Risk Factors | 6 | 2012 | 74840 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2011 | 15652 | 0.030 |
Why?
|
| Clinical Competence | 2 | 2000 | 4863 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2016 | 479 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 15880 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2006 | 3850 | 0.030 |
Why?
|
| Hyperkalemia | 1 | 1996 | 233 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1999 | 1158 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1996 | 900 | 0.030 |
Why?
|
| Odds Ratio | 3 | 2011 | 9649 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 4958 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2000 | 1064 | 0.030 |
Why?
|
| Risk | 3 | 2013 | 9591 | 0.030 |
Why?
|
| Age Factors | 2 | 2021 | 18380 | 0.030 |
Why?
|
| Insulin | 4 | 2011 | 6599 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 5783 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 988 | 0.020 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1992 | 123 | 0.020 |
Why?
|
| Genetic Association Studies | 2 | 2011 | 2741 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1996 | 1206 | 0.020 |
Why?
|
| Aldosterone | 1 | 1996 | 881 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1996 | 1145 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2601 | 0.020 |
Why?
|
| Cardiac Output | 2 | 1991 | 840 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2021 | 2033 | 0.020 |
Why?
|
| Ventricular Function, Left | 3 | 1996 | 3928 | 0.020 |
Why?
|
| Diltiazem | 1 | 1991 | 132 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1996 | 1441 | 0.020 |
Why?
|
| Glutamine | 1 | 2013 | 576 | 0.020 |
Why?
|
| Reference Values | 1 | 2017 | 4908 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2000 | 2172 | 0.020 |
Why?
|
| Catecholamines | 2 | 1996 | 383 | 0.020 |
Why?
|
| Nifedipine | 1 | 1990 | 220 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2005 | 10383 | 0.020 |
Why?
|
| Cardiology | 1 | 2000 | 1702 | 0.020 |
Why?
|
| Double-Blind Method | 5 | 2005 | 12437 | 0.020 |
Why?
|
| Health Status | 2 | 2017 | 4080 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39193 | 0.020 |
Why?
|
| Thallium | 1 | 1987 | 94 | 0.020 |
Why?
|
| Time Factors | 4 | 2017 | 40065 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 1991 | 1515 | 0.020 |
Why?
|
| Sex Factors | 1 | 2021 | 10603 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1996 | 1799 | 0.020 |
Why?
|
| Forecasting | 1 | 1996 | 2936 | 0.020 |
Why?
|
| Homeostasis | 2 | 1996 | 3336 | 0.020 |
Why?
|
| Receptors, Adiponectin | 1 | 2006 | 82 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2000 | 3529 | 0.020 |
Why?
|
| Angioplasty, Laser | 1 | 2005 | 19 | 0.020 |
Why?
|
| Radioisotopes | 1 | 1987 | 495 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 355 | 0.010 |
Why?
|
| Base Sequence | 2 | 2006 | 12403 | 0.010 |
Why?
|
| Caffeine | 1 | 1989 | 702 | 0.010 |
Why?
|
| Physical Education and Training | 1 | 1984 | 102 | 0.010 |
Why?
|
| Ketosis | 1 | 1983 | 46 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12795 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1992 | 2186 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 1056 | 0.010 |
Why?
|
| Gonadotropins | 1 | 1984 | 240 | 0.010 |
Why?
|
| Genome-Wide Association Study | 2 | 2013 | 12807 | 0.010 |
Why?
|
| Phenotype | 2 | 2011 | 16721 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 1986 | 538 | 0.010 |
Why?
|
| Anemia | 1 | 1992 | 1511 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1996 | 3242 | 0.010 |
Why?
|
| Aging | 2 | 1992 | 8731 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1983 | 261 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1993 | 3096 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1775 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1984 | 566 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 218 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2017 | 3785 | 0.010 |
Why?
|
| Acidosis | 1 | 1983 | 271 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 14652 | 0.010 |
Why?
|
| Placebo Effect | 1 | 2005 | 514 | 0.010 |
Why?
|
| Radionuclide Angiography | 1 | 2000 | 23 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6547 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2391 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10563 | 0.010 |
Why?
|
| Pyridones | 1 | 1986 | 816 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 2229 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4247 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12976 | 0.010 |
Why?
|
| Echocardiography, Doppler | 2 | 1996 | 899 | 0.010 |
Why?
|
| Computational Biology | 1 | 2011 | 3559 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22332 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1999 | 243 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 1999 | 240 | 0.010 |
Why?
|
| Blood Flow Velocity | 2 | 1993 | 1381 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15842 | 0.010 |
Why?
|
| 5'-Nucleotidase | 1 | 1999 | 160 | 0.010 |
Why?
|
| Leptin | 1 | 2006 | 1596 | 0.010 |
Why?
|
| Heparin | 1 | 2005 | 1630 | 0.010 |
Why?
|
| Echocardiography | 3 | 2000 | 5045 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9525 | 0.010 |
Why?
|
| Estrogens | 1 | 1984 | 1529 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1983 | 1870 | 0.010 |
Why?
|
| Random Allocation | 2 | 1992 | 2395 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2002 | 659 | 0.010 |
Why?
|
| Algorithms | 1 | 1996 | 14071 | 0.010 |
Why?
|
| Hypotension | 1 | 2002 | 885 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6897 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1996 | 364 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1996 | 398 | 0.010 |
Why?
|
| Energy Intake | 1 | 1983 | 2141 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15398 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 10729 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29922 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 2081 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1996 | 345 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2006 | 3312 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 1377 | 0.010 |
Why?
|
| Models, Structural | 1 | 1993 | 338 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2011 | 13039 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21480 | 0.010 |
Why?
|
| Hemodilution | 1 | 1992 | 120 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1996 | 1029 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17594 | 0.010 |
Why?
|
| Blood Component Transfusion | 1 | 1992 | 138 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 5020 | 0.010 |
Why?
|
| Hematocrit | 1 | 1992 | 621 | 0.010 |
Why?
|
| Hypertension | 1 | 2011 | 8626 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81819 | 0.010 |
Why?
|
| United States | 2 | 2013 | 72903 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2006 | 3424 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1992 | 15747 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 3634 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9601 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 26318 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2005 | 4862 | 0.010 |
Why?
|
| Diastole | 1 | 1992 | 785 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11888 | 0.000 |
Why?
|
| Adenosine | 1 | 1993 | 806 | 0.000 |
Why?
|
| Down-Regulation | 1 | 1996 | 2927 | 0.000 |
Why?
|
| Societies, Medical | 1 | 2000 | 3956 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1996 | 2599 | 0.000 |
Why?
|
| Physical Fitness | 1 | 1992 | 742 | 0.000 |
Why?
|
| Treatment Outcome | 2 | 2005 | 65188 | 0.000 |
Why?
|
| Heart Rate | 2 | 1988 | 4204 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1993 | 36532 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1986 | 395 | 0.000 |
Why?
|
| Milrinone | 1 | 1986 | 87 | 0.000 |
Why?
|
| Phentolamine | 1 | 1985 | 102 | 0.000 |
Why?
|
| Animals | 1 | 2017 | 168764 | 0.000 |
Why?
|
| Pediatrics | 1 | 2000 | 3606 | 0.000 |
Why?
|
| Diet | 1 | 1983 | 8086 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1985 | 170 | 0.000 |
Why?
|
| Bicarbonates | 1 | 1985 | 293 | 0.000 |
Why?
|
| Propranolol | 1 | 1985 | 492 | 0.000 |
Why?
|
| Myocardium | 1 | 1996 | 4760 | 0.000 |
Why?
|
| Glycogen | 1 | 1983 | 251 | 0.000 |
Why?
|
| Menstruation | 1 | 1984 | 309 | 0.000 |
Why?
|
| Child | 2 | 2000 | 80564 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 4850 | 0.000 |
Why?
|
| Heart Failure | 1 | 1986 | 11840 | 0.000 |
Why?
|
| Body Temperature | 1 | 1984 | 779 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1985 | 2477 | 0.000 |
Why?
|
| Blood Glucose | 2 | 1985 | 6424 | 0.000 |
Why?
|
| Muscles | 1 | 1983 | 1578 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1986 | 4015 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2000 | 42500 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 59489 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1990 | 9347 | 0.000 |
Why?
|
| Adolescent | 2 | 1993 | 88835 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1986 | 8041 | 0.000 |
Why?
|